Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
TOXOPLASMA GONDII TACHYZOITES S48
Intervet Ireland Limited
QI04AN01
TOXOPLASMA GONDII TACHYZOITES S48
Unknown
Concentrate for Soln for Inj
POM
Ovine
Toxoplasma vaccine
Immunological - Live Vaccine
Authorised
2003-08-18
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Toxovax 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 ml dose of diluted vaccine contains: ACTIVE SUBSTANCE: 10 5 _Toxoplasma gondii _tachyzoites S48 For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Concentrate and diluent for suspension for injection. Concentrate: cloudy suspension. Diluent: colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep (ewes). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of susceptible breeding female sheep to reduce the effects of infection by _Toxoplasma_ _gondii_, namely early embryonic death, barrenness and abortion. Vaccination with Toxovax is known to protect for at least two lambing seasons. 4.3 CONTRAINDICATIONS Do not vaccinate animals less than 3 weeks before mating. Do not use during pregnancy. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Toxoplasma is only one of the causes of abortion in sheep. Where abortion occurs in sheep which have been vaccinated with Toxovax then it is recommended that veterinary advice is sought immediately to clarify the likely cause. Care should be taken in handling such abortions as susceptible humans may be at risk of infection. A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system. Immunogenicity of the vaccine antigen will be reduced by poor storage or inappropriate administration. Immuno- competence of the animal may be compromised by a variety of factors including poor health, nutritional status, genetic factors, concurrent drug therapy and stress. Only healthy animals should be vaccinated. IRISH MEDICINES BOARD ____________________________________________________________________________________________________________ Preberite celoten dokument